Amir Manbachi | |
---|---|
Nationality | Iranian-born Canadian-American |
Occupation | Professor |
Academic background | |
Alma mater | University of Toronto |
Academic work | |
Discipline | |
Institutions | |
Notable works | Towards Ultrasound-guided Spinal Fusion Surgery (2018) |
Amir Manbachi ( Persian: امیر منبع چی) is an Iranian-born, Canadian-American academic and researcher, currently working as an Associate Professor of Neurosurgery and Biomedical Engineering at Johns Hopkins School of Medicine, and known for his work in Medical Ultrasound. [1] He is the co-founder and current director of HEPIUS Innovation Lab at Johns Hopkins University. [2]
Manbachi is of Iranian descent. [2] He attended the University of Toronto, where he completed his bachelor's degree in applied sciences (BASc) in the Engineering Science (Physics) program. [3] Later, he obtained his master's degree and a PhD in biomedical engineering at the University of Toronto. [3] [2] [4] During his third year as a PhD candidate, he, along with his university advisers, established Spinesonics Medical which developed a sensor designed to aid in vertebral screw insertion procedures. [5] [6] They received $850,000 of grant funding to support their research and development efforts. [5]
In 2016, Manbachi joined the Department of Biomedical Engineering at Johns Hopkins University as a research faculty member. [3] [7] At Johns Hopkins University, he co-founded HEPIUS Innovation Labs and now serves as its director. [8] [9] He also served as an associate director of the Center for Bioengineering Innovation and Design. [10]
In 2018, Manbachi and Nao J. Gamo began researching ultrasound technology with the potential to target and "burn" brain tumors. [10] They received a total of $750,000 in grant funding from Hopkins, Maryland Technology Development Corp., and the Wallace H. Coulter Foundation for this purpose. [10]
In 2020, Manbachi and a team co-led by Nicholas Theodore at Johns Hopkins Medicine were awarded a $13.5M grant from the Defense Advanced Research Projects Agency (DARPA) to research wearable and implantable ultrasound technologies for spinal cord injury patients. [11] [12]
In 2022, Manbachi received Baltimore Business Journal's 40 under 40 award, and secured a Johns Hopkins Discovery award. [2]
In 2023, the HEPIUS Innovation Lab at Hopkins, led by Manbachi, received a Food and Drug Administration Breakthrough Device Designation for a novel ultrasound imaging implant. [9] [13]
In 2024, he received American Institute of Ultrasound in Medicine's Peter Arger Excellence in Medical Student Education Award as well as the Hisako Terasaki's Young Innovator Award. [14] [15] [16]
This article needs additional or more specific
categories. (January 2024) |
Amir Manbachi | |
---|---|
Nationality | Iranian-born Canadian-American |
Occupation | Professor |
Academic background | |
Alma mater | University of Toronto |
Academic work | |
Discipline | |
Institutions | |
Notable works | Towards Ultrasound-guided Spinal Fusion Surgery (2018) |
Amir Manbachi ( Persian: امیر منبع چی) is an Iranian-born, Canadian-American academic and researcher, currently working as an Associate Professor of Neurosurgery and Biomedical Engineering at Johns Hopkins School of Medicine, and known for his work in Medical Ultrasound. [1] He is the co-founder and current director of HEPIUS Innovation Lab at Johns Hopkins University. [2]
Manbachi is of Iranian descent. [2] He attended the University of Toronto, where he completed his bachelor's degree in applied sciences (BASc) in the Engineering Science (Physics) program. [3] Later, he obtained his master's degree and a PhD in biomedical engineering at the University of Toronto. [3] [2] [4] During his third year as a PhD candidate, he, along with his university advisers, established Spinesonics Medical which developed a sensor designed to aid in vertebral screw insertion procedures. [5] [6] They received $850,000 of grant funding to support their research and development efforts. [5]
In 2016, Manbachi joined the Department of Biomedical Engineering at Johns Hopkins University as a research faculty member. [3] [7] At Johns Hopkins University, he co-founded HEPIUS Innovation Labs and now serves as its director. [8] [9] He also served as an associate director of the Center for Bioengineering Innovation and Design. [10]
In 2018, Manbachi and Nao J. Gamo began researching ultrasound technology with the potential to target and "burn" brain tumors. [10] They received a total of $750,000 in grant funding from Hopkins, Maryland Technology Development Corp., and the Wallace H. Coulter Foundation for this purpose. [10]
In 2020, Manbachi and a team co-led by Nicholas Theodore at Johns Hopkins Medicine were awarded a $13.5M grant from the Defense Advanced Research Projects Agency (DARPA) to research wearable and implantable ultrasound technologies for spinal cord injury patients. [11] [12]
In 2022, Manbachi received Baltimore Business Journal's 40 under 40 award, and secured a Johns Hopkins Discovery award. [2]
In 2023, the HEPIUS Innovation Lab at Hopkins, led by Manbachi, received a Food and Drug Administration Breakthrough Device Designation for a novel ultrasound imaging implant. [9] [13]
In 2024, he received American Institute of Ultrasound in Medicine's Peter Arger Excellence in Medical Student Education Award as well as the Hisako Terasaki's Young Innovator Award. [14] [15] [16]
This article needs additional or more specific
categories. (January 2024) |